We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Leukocyte Differential Compared on Flow Cytometry Hematology Analyzer

By LabMedica International staff writers
Posted on 10 Sep 2012
A recently introduced automated hematology analyzer that provides a 16-part white blood cell count (WBC) differential has been compared with other automated machines and the manual method. More...


The newer flow cytometry-hematology analyzer is not only able to differentiate the five main white cell populations but also capable of distinguishing 11 other cells including immature blast cells and various T-lymphocytes.

Scientists at Dong-A University (Busan, South Korea) selected 101 blood samples in routine complete blood counts (CBC) for analysis regardless of previous diagnosis. The samples came from 54 men and 47 women, whose age range was 1-84 years, with a mean age of 43 years. The Hematoflow, the newest automatic hematology analyzer, includes a DxH 800 Coulter Cellular Analysis System and FC 500 Flow Cytometer (Beckman Coulter; Miami, FL, USA). The DxH800 uses multiple angles of light scatter, and the FC500 provides a 16-part WBC differential, giving precise information on WBC subsets.

The FC500 contains a premixed Cytodiff reagent and analysis software. The Cytodiff panel included six directly conjugated monoclonal antibodies in a five-color single reagent. The differential WBC count performance of the FC500, was compared with the Beckman Coulter DxH800, the Sysmex XE-2100 (TOA Medical Electronics Co.; Kobe, Japan), and the reference manual method. The methodological comparison of the WBC differential parameters of neutrophils, lymphocytes, monocytes and eosinophils showed good correlations among four different analyses. More than 1% of blast cells were counted in 30 of 101 samples.

For B-cell acute lymphatic leukaemia (ALL), blast B count of Hematoflow shows good correlation with reference method results. The analyzer easily distinguished B-cell lineage leukemic blasts from T-cell leukemic blasts and myeloblasts. For T-cell ALL, Hematoflow did not identify blast T, and shows complete agreement with manual counting. For acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), blast non-B-non-T counts of Hematoflow shows 100% concordance and good correlation with reference method results.

The scientists concluded that for the technical staff, the installation of Hematoflow would have many consequences. There would be a reduction in technical staff time at the microscope while simultaneously increasing the efficiency of the workflow, the elimination of medical technologists facing a difficult diagnosis alone. This rapid and quantitative technique may be helpful in the differential diagnosis of acute leukemias prior to additional investigation. The study was published in the October 2012 edition of the International Journal of Laboratory Hematology.

Related Links:

Dong-A University
Beckman Coulter
TOA Medical Electronics Co.



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.